Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS

(DGX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
125.99(c) 127.36(c) 125.18(c) 124.46(c) 124.97(c) Last
1 029 545 1 114 080 1 070 324 1 394 487 905 278 Volume
+1.29% +1.09% -1.71% -0.58% +0.41% Change
More quotes
Financials (USD)
Sales 2020 9 360 M - -
Net income 2020 1 373 M - -
Net Debt 2020 2 899 M - -
P/E ratio 2020 12,7x
Yield 2020 1,77%
Sales 2021 9 461 M - -
Net income 2021 1 202 M - -
Net Debt 2021 2 861 M - -
P/E ratio 2021 14,2x
Yield 2021 1,85%
Capitalization 16 842 M 16 842 M -
EV / Sales 2020 2,11x
EV / Sales 2021 2,08x
Nbr of Employees 47 000
Free-Float 61,9%
More Financials
Company
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (95.8%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (4.3%).  
More about the company
Notations Surperformance© of Quest Diagnostics
Trading Rating : Investor Rating :
More Ratings
All news about QUEST DIAGNOSTICS
01/19QUEST DIAGNOSTICS : Obtains CDC Contract for COVID-19 Genomic Sequencing
MT
01/19QUEST DIAGNOSTICS : Ex-dividend day for
FA
01/18QUEST DIAGNOSTICS : Black and Hispanic/Latinx Americans Less Confident in Abilit..
PR
01/18QUEST DIAGNOSTICS : Granted CDC Contract to Sequence COVID-19 Gene Variants to A..
PR
01/13QUEST DIAGNOSTICS : To Release Fourth Quarter And Full Year 2020 Financial Resul..
PR
01/07QUEST DIAGNOSTICS : Form4
PU
01/07INSIDER TRENDS : Insider at Quest Diagnostics Sells for Tax Adds to 90-Day Selli..
MT
01/05QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
2020QUEST DIAGNOSTICS : Form4
PU
2020QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
2020COVID SCIENCE-Oxygen level while walking identifies at-risk patients; cancer ..
RE
2020IQVIA-Quest Diagnostics Joint Venture Q2 Form Marketing Partnership With Adap..
MT
2020QUEST DIAGNOSTICS : Leading Black Clergy Meet with Dr. Fauci and Nation's Top Do..
PR
2020QUEST DIAGNOSTICS : and The Commons Project to Deliver Convenient Access to Lab ..
PR
2020SECTOR UPDATE : Health Care Stocks Steady Premarket Wednesday
MT
More news
News in other languages on QUEST DIAGNOSTICS
2020Menge an Corona-Tests stellt USA auf die Probe
2020QUEST DIAGNOSTICS : publication des résultats semestriels
2020QUEST DIAGNOSTICS : Veröffentlichung des Halbjahresergebnisses
2020GENOMIC VISION : perte nette réduite d'un tiers en 2019
2020Les valeurs à suivre aujourd'hui à la Bourse de Paris Vendredi 22 mai 2020
More news
Analyst Recommendations on QUEST DIAGNOSTICS
More recommendations
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | DGX | US74834L1008 | MarketScreener
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 139,88 $
Last Close Price 124,97 $
Spread / Highest target 20,8%
Spread / Average Target 11,9%
Spread / Lowest Target -3,18%
EPS Revisions
Managers and Directors
NameTitle
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Gail R. Wilensky Independent Director